The Company is a Korea-based company principally engaged in manufacture of pharmaceutical products. The Company s products mainly consist of generic active pharmaceutical ingredients (APIs), such as tipepidine hibenzate, doxifluridine, clopidogrel bisulfate, voriconazole and new medicine APIs, such as small molecule APIs. The Company distributes its products within domestic market and to overseas markets. The Company was established on August 18, 2008. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on Jun 23, 2016.
Headquarters
231, Hyeopryeok-Ro, Siheung-Si, Gyeonggi-Do
Siheung; Gyeonggi;
Contact Details: Purchase the St Pharm Co., Ltd. (Siheung) report to view the information.
Website: http://www.stpharm.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service